Sorrento Therapeutics (SRNE)

Sorrento Therapeutics (SRNE) Cash flow


Sorrento Therapeutics Cash Flow

SRNE's free cash flow for Q was $-65.01M. For the fiscal year, SRNE's free cash flow was decreased by $-124.63M and operating cash flow was $-61.17M. See a summary of the company’s cash flow.
Cash Flow
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
$ -297.66M$ -281.82M$ -159.54M$ -173.00M$ -111.77M$ -99.18M
Investing Cash Flow
$ -25.69M$ 79.85M$ -39.92M$ -38.17M$ -21.20M$ -16.53M
Financing Cash Flow
$ 357.50M$ 181.33M$ 174.24M$ 78.89M$ 326.00M$ 53.67M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 289.60M$ 36.66M$ 56.46M$ 80.77M$ 213.33M$ 20.43M
Income Tax Paid Supplemental Data
$ 29.00K$ 1.20M$ 0.00$ 13.00K$ 6.00K$ 34.00K
Interest Paid Supplemental Data
$ 1.64M$ 1.06M$ 3.42M$ 12.74M$ 1.62M$ 3.50M
Issuance Of Capital Stock
$ 406.98M$ 201.82M$ 317.87M$ 47.70M$ 83.61M$ 57.93M
Issuance Of Debt
$ 113.25M$ 49.74M$ 18.59M$ 25.41M$ 284.64M$ 49.92M
Repayment Of Debt
$ -165.73M$ -85.66M$ -205.56M$ -3.07M$ -42.47M$ -53.16M
Free Cash Flow
$ -309.00M$ -290.69M$ -166.06M$ -184.44M$ -122.96M$ -110.15M
Domestic Sales
Foreign Sales
Currency in USD

Sorrento Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis